Investors Buy Shares of MetLife, Inc. (MET) on Weakness

Investors purchased shares of MetLife, Inc. (NYSE:MET) on weakness during trading hours on Tuesday. $56.22 million flowed into the stock on the tick-up and $27.69 million flowed out of the stock on the tick-down, for a money net flow of $28.53 million into the stock. Of all companies tracked, MetLife had the 24th highest net in-flow for the day. MetLife traded down ($0.49) for the day and closed at $52.38

Several analysts recently commented on the stock. Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a research note on Wednesday. Goldman Sachs Group, Inc. (The) assumed coverage on shares of MetLife in a research note on Wednesday. They set a “conviction-buy” rating and a $61.00 target price for the company. FBR & Co lowered shares of MetLife from a “buy” rating to a “neutral” rating and cut their target price for the company from $53.00 to $52.00 in a research note on Tuesday, October 10th. ValuEngine lowered shares of MetLife from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 10th. Finally, Zacks Investment Research raised shares of MetLife from a “strong sell” rating to a “hold” rating in a research note on Monday, October 9th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $57.62.

The company has a market cap of $56.12 billion, a PE ratio of 621.18 and a beta of 1.47. The firm’s 50-day moving average is $50.42 and its 200-day moving average is $48.03.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The business had revenue of $17.39 billion for the quarter, compared to analyst estimates of $17.11 billion. During the same quarter last year, the firm earned $0.83 EPS. MetLife’s quarterly revenue was up 2.5% compared to the same quarter last year. Equities research analysts expect that MetLife, Inc. will post $4.81 earnings per share for the current year.

A number of institutional investors have recently added to or reduced their stakes in the stock. Waldron LP lifted its stake in MetLife by 5.1% in the first quarter. Waldron LP now owns 6,492 shares of the financial services provider’s stock valued at $342,000 after buying an additional 315 shares in the last quarter. Northwestern Mutual Investment Management Company LLC lifted its stake in MetLife by 74.1% in the first quarter. Northwestern Mutual Investment Management Company LLC now owns 219,781 shares of the financial services provider’s stock valued at $11,609,000 after buying an additional 93,569 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in MetLife by 4.7% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 11,153 shares of the financial services provider’s stock valued at $589,000 after buying an additional 497 shares in the last quarter. Marietta Wealth Management LLC bought a new position in MetLife in the first quarter valued at approximately $416,000. Finally, Tiedemann Wealth Management LLC lifted its stake in MetLife by 98.2

Several analysts recently commented on the stock. Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a research note on Wednesday. Goldman Sachs Group, Inc. (The) assumed coverage on shares of MetLife in a research note on Wednesday. They set a “conviction-buy” rating and a $61.00 target price for the company. FBR & Co lowered shares of MetLife from a “buy” rating to a “neutral” rating and cut their target price for the company from $53.00 to $52.00 in a research note on Tuesday, October 10th. ValuEngine lowered shares of MetLife from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 10th. Finally, Zacks Investment Research raised shares of MetLife from a “strong sell” rating to a “hold” rating in a research note on Monday, October 9th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $57.62.

The company has a market cap of $56.12 billion, a PE ratio of 621.18 and a beta of 1.47. The firm’s 50-day moving average is $50.42 and its 200-day moving average is $48.03.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The business had revenue of $17.39 billion for the quarter, compared to analyst estimates of $17.11 billion. During the same quarter last year, the firm earned $0.83 EPS. MetLife’s quarterly revenue was up 2.5% compared to the same quarter last year. Equities research analysts expect that MetLife, Inc. will post $4.81 earnings per share for the current year.

A number of institutional investors have recently added to or reduced their stakes in the stock. Waldron LP lifted its stake in MetLife by 5.1% in the first quarter. Waldron LP now owns 6,492 shares of the financial services provider’s stock valued at $342,000 after buying an additional 315 shares in the last quarter. Northwestern Mutual Investment Management Company LLC lifted its stake in MetLife by 74.1% in the first quarter. Northwestern Mutual Investment Management Company LLC now owns 219,781 shares of the financial services provider’s stock valued at $11,609,000 after buying an additional 93,569 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in MetLife by 4.7% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 11,153 shares of the financial services provider’s stock valued at $589,000 after buying an additional 497 shares in the last quarter. Marietta Wealth Management LLC bought a new position in MetLife in the first quarter valued at approximately $416,000. Finally, Tiedemann Wealth Management LLC lifted its stake in MetLife by 98.2% in the first quarter. Tiedemann Wealth Management LLC now owns 17,352 shares of the financial services provider’s stock valued at $917,000 after buying an additional 8,595 shares in the last quarter. 74.22% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Investors Buy Shares of MetLife, Inc. (MET) on Weakness” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://ledgergazette.com/2017/10/19/investors-buy-shares-of-metlife-inc-met-on-weakness.html.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply